N. Bernard

发表

HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)

Wildo Navegantes de Araújo, M. Ziol, V. Paradis, 2019, AIDS and Behavior.

Pravastatin in HIV-Infected Patients Treated with Protease Inhibitors: A Placebo-Controlled Randomized Study

D. Breilh, P. Morlat, F. Dabis, 2007, HIV clinical trials.

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

M. Ziol, C. Delaugerre, C. Katlama, 2022, AIDS Research and Therapy.

Incidence of cytomegalovirus disease in the Aquitaine cohort of HIV-infected patients: a retrospective survey, 1987-1993. Groupe d'Epidémilogie Clinique du SIDA en Aquitaine (GECSA).

J. Ragnaud, P. Morlat, F. Dabis, 1997, Journal of Infection.

A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.

S. Lawson-Ayayi, P. Morlat, F. Dabis, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CASE REPORT: Sarcoidosis-Associated Hepatitis C Virus Infection

P. Morlat, F. Bonnet, D. Lacoste, 2002, Digestive Diseases and Sciences.

Increases in CD3+CD4-CD8- T lymphocytes in AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection.

J. Ragnaud, M. Dupon, F. Dabis, 1996, The Journal of infectious diseases.

Prevalence and underestimation of pain in HIV-infected patients by physicians: a cross-sectional study in a day care hospital.

P. Morlat, G. Chêne, D. Lacoste, 1999, AIDS.

Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA).

P. Couzigou, M. Dupon, F. Dabis, 1999, AIDS.

Liver‐related mortality in human‐immunodeficiency‐virus‐infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study) *

S. Pol, C. Michelet, C. Pradier, 2007, Journal of viral hepatitis.

Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.

M. Dupon, P. Morlat, J. Pellegrin, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Prognostic factors of survival of HIV-infected patients with Cytomegalovirus disease: Aquitaine Cohort, 1986–1997

F. Dabis, M. Rougier, C. Binquet, 2000, European Journal of Epidemiology.

Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

F. Dabis, M. Rougier, C. Binquet, 2000, European journal of epidemiology.

Sarcoidosis-associated hepatitis C virus infection.

P. Morlat, F. Bonnet, D. Lacoste, 2002, Digestive diseases and sciences.

Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

F. Dabis, L. Dequae-Merchadou, V. Journot, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy.

R. Salamon, P. Morlat, G. Chêne, 2001, Clinical immunology.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.

P. Morlat, F. Bonnet, J. Taupin, 2003, The Journal of rheumatology.

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

M. Ziol, V. Paradis, C. Delaugerre, 2020, Journal of hepatology.

Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.

B. Masquelier, D. Neau, J. Ragnaud, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[Isolated involvement of the trigeminal nerve of sarcoidosis origin].

P. Morlat, F. Bonnet, H. Loiseau, 1997, Revue neurologique.

The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir

P. Morlat, F. Bonnet, I. Delèvaux, 2001, International journal of STD & AIDS.

Correlations of Soluble Interleukin-2 and Tumor Necrosis Factor Type II Receptors with Immunologic and Virologic Responses Under HAART

R. Salamon, P. Morlat, G. Chêne, 2002, Journal of Clinical Immunology.

A possible association between Chlamydiae psittacci infection and temporal arteritis.

P. Morlat, F. Bonnet, M. Parrens, 2000, Joint, bone, spine : revue du rhumatisme.

[Severe lactic acidosis in HIV-infected patients treated with nucleosidic reverse transcriptase analogs: a report of 9 cases].

M. Dupon, P. Morlat, J. Pellegrin, 2003, La Revue de medecine interne.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV)

V. Gaborieau, G. Iles, D. Breilh, 2023, BMC Infectious Diseases.

Survival of HIV-infected patients with cytomegalovirus retinitis under highly active antiretroviral therapy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

F. Dabis, C. Binquet, C. Marimoutou, 1998, AIDS.

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

C. Katlama, D. Neau, M. Dupon, 2018, Journal of viral hepatitis.

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

C. Katlama, M. Shoai, H. Melliez, 2018, The Journal of antimicrobial chemotherapy.